{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:39:38Z","timestamp":1789007978747,"version":"build-2803163510"},"reference-count":112,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jaad.2017.11.063","type":"journal-article","created":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T22:04:35Z","timestamp":1523397875000},"page":"1009-1022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["Neutrophilic dermatoses"],"prefix":"10.1016","volume":"79","author":[{"given":"Hovik J.","family":"Ashchyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline A.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasha","family":"Stephen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Micheletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misha","family":"Rosenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2017.11.063_bib1","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/j.1468-3083.2009.03199.x","article-title":"Pyoderma gangrenosum: an updated review","volume":"23","author":"Ruocco","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.11.063_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00005792-200001000-00004","article-title":"Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions","volume":"79","author":"Bennett","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaad.2017.11.063_bib3","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1365-2133.2011.10565.x","article-title":"Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients","volume":"165","author":"Binus","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jamadermatol.2017.5978","article-title":"The association of age with clinical presentation and comorbidities of pyoderma gangrenosum","volume":"154","author":"Ashchyan","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/11595240-000000000-00000","article-title":"Etiology and management of pyoderma gangrenosum: a comprehensive review","volume":"13","author":"Ahronowitz","year":"2012","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib6","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0190-9622(88)70074-2","article-title":"Superficial granulomatous pyoderma: a localized vegetative form of pyoderma gangrenosum","volume":"18","author":"Wilson-Jones","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archderm.1968.01610180005001","article-title":"Malignant pyodermas","volume":"98","author":"Perry","year":"1968","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib8","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/archderm.1978.01640190049017","article-title":"A diffuse pustular eruption associated with ulcerative colitis","volume":"114","author":"O'Loughlin","year":"1978","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib9","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1600-0714.2012.01152.x","article-title":"Pyostomatitis vegetans and its relation to inflammatory bowel disease, pyoderma gangrenosum, pyodermatitis vegetans, and pemphigus","volume":"41","author":"Nico","year":"2012","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.jaad.2017.11.063_bib10","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/jama.284.12.1546","article-title":"Clinical features and treatment of peristomal pyoderma gangrenosum","volume":"284","author":"Hughes","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2017.11.063_bib11","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jaad.2015.06.054","article-title":"Postoperative pyoderma gangrenosum (PG): the Mayo Clinic experience of 20 years from 1994 through 2014","volume":"73","author":"Tolkachjov","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib12","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1111\/jdv.13976","article-title":"Pyoderma gangrenosum with extensive pulmonary involvement","volume":"31","author":"Scherlinger","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.11.063_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/ICO.0b013e31802eb078","article-title":"Sclerokeratitis and facial skin lesions: a case report of pyoderma gangrenosum and its response to dapsone therapy","volume":"26","author":"Teasley","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.jaad.2017.11.063_bib14","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2133.1999.03055.x","article-title":"Pyoderma gangrenosum with liver, spleen and bone involvement in a patient with chronic myelomonocytic leukaemia","volume":"141","author":"Vadillo","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1525-1470.1999.00058.x","article-title":"Neutrophilic dermatosis-associated sterile chronic multifocal osteomyelitis in pediatric patients: case report and review","volume":"16","author":"Nurre","year":"1999","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib16","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1365-4632.2004.02128.x","article-title":"Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria","volume":"43","author":"Su","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jamadermatol.2017.5980","article-title":"Diagnostic criteria of ulcerative pyoderma gangrenosum: A Delphi consensus of international experts","volume":"154","author":"Maverakis","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00129334-200105000-00015","article-title":"Diagnosing pyoderma gangrenosum","volume":"14","author":"Trent","year":"2001","journal-title":"Adv Skin Wound Care"},{"key":"10.1016\/j.jaad.2017.11.063_bib19","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa013383","article-title":"Skin ulcers misdiagnosed as pyoderma gangrenosum","volume":"347","author":"Weenig","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2017.11.063_bib20","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0190-9622(96)90076-6","article-title":"Pyoderma gangrenosum in a patient with cryoglobulinemia and hepatitis C successfully treated with interferon alfa","volume":"34","author":"Smith","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2230.1992.tb00206.x","article-title":"Wegener's granulomatosis presenting as pyoderma gangrenosum","volume":"17","author":"Handfield-Jones","year":"1992","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib22","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000246828","article-title":"Pyoderma-gangraenosum-like ulcers associated with lupus anticoagulant","volume":"189","author":"Selva","year":"1994","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2017.11.063_bib23","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1046\/j.1365-2133.2000.03253.x","article-title":"Mycosis fungoides bullosa simulating pyoderma gangrenosum","volume":"142","author":"Ho","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib24","first-page":"335","article-title":"Pyoderma gangrenosum or cutaneous lymphoma: a difficult clinical diagnosis","volume":"42","author":"Vose","year":"1988","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2017.11.063_bib25","first-page":"463","article-title":"Bullous pyoderma gangrenosum as a manifestation of leukemia cutis","volume":"10","author":"Torok","year":"2000","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib26","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/archderm.1986.01660180097024","article-title":"Sporotrichosis masquerading as pyoderma gangrenosum","volume":"122","author":"Spiers","year":"1986","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0190-9622(81)70074-4","article-title":"Cutaneous cryptococcosis simulating pyoderma gangrenosum","volume":"5","author":"Massa","year":"1981","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1046\/j.1365-4362.2000.00843.x","article-title":"Cutaneous tuberculosis and pyoderma gangrenosum","volume":"39","author":"Matsui","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib29","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.rdc.2007.07.016","article-title":"Pyoderma gangrenosum: an update","volume":"33","author":"Callen","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.jaad.2017.11.063_bib30","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1610-0387.2010.07535.x","article-title":"Etiology of chronic leg ulcers in 31,619 patients in Germany analyzed by an expert survey","volume":"9","author":"Korber","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2017.11.063_bib31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/archdermatol.2010.393","article-title":"Is topical monotherapy effective for localized pyoderma gangrenosum?","volume":"147","author":"Le Cleach","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib32","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jaad.2016.06.016","article-title":"Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: a prospective cohort study","volume":"75","author":"Thomas","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib33","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jaad.2016.05.044","article-title":"Clinical features, causes, treatments, and outcomes of peristomal pyoderma gangrenosum (PPG) in 44 patients: the Mayo Clinic experience, 1996 through 2013","volume":"75","author":"Barbosa","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/095466301750163518","article-title":"Topical tacrolimus in the management of peristomal pyoderma gangrenosum","volume":"12","author":"Lyon","year":"2001","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2017.11.063_bib35","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/09546630903268239","article-title":"Topical tacrolimus for the treatment of localized, idiopathic, newly diagnosed pyoderma gangrenosum","volume":"21","author":"Marzano","year":"2010","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2017.11.063_bib36","first-page":"555","article-title":"Successful topical tacrolimus (FK506) therapy in a child with pyoderma gangrenosum","volume":"34","author":"Kimble","year":"2002","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaad.2017.11.063_bib37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1468-3083.2007.02280.x","article-title":"Successful treatment of severe pyoderma gangrenosum with pimecrolimus cream 1%","volume":"22","author":"Bellini","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.11.063_bib38","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0190-9622(83)70172-6","article-title":"Pyoderma gangrenosum: successful treatment with intralesional steroids","volume":"9","author":"Jennings","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/archderm.1967.01600310127029","article-title":"Pyoderma gangrenosum. A patient successfully treated with intralesional injections of steroid","volume":"95","author":"Moschella","year":"1967","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib40","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2133.1991.tb14783.x","article-title":"Clearing of pyoderma gangrenosum by intralesional cyclosporin A","volume":"125","author":"Mrowietz","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib41","doi-asserted-by":"crossref","first-page":"h2958","DOI":"10.1136\/bmj.h2958","article-title":"Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial","volume":"350","author":"Ormerod","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2017.11.063_bib42","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0190-9622(96)90285-6","article-title":"Treatment of pyoderma gangrenosum","volume":"34","author":"Chow","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib43","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.3748\/wjg.14.5471","article-title":"Atypical presentation of pioderma gangrenosum complicating ulcerative colitis: rapid disappearance with methylprednisolone","volume":"14","author":"Aseni","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jaad.2017.11.063_bib44","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1016\/j.jaad.2009.11.683","article-title":"Rapid resolution of pyoderma gangrenosum after treatment with intravenous cyclosporine","volume":"63","author":"Turner","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib45","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1097\/01.PRS.0000112762.22427.C4","article-title":"Stabilization of pyoderma gangrenosum ulcer with oral cyclosporine prior to skin grafting","volume":"113","author":"Zakhireh","year":"2004","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jaad.2017.11.063_bib46","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1046\/j.1468-3083.2002.00387.x","article-title":"Successful treatment of postoperative pyoderma gangrenosum with cyclosporin","volume":"16","author":"Schofer","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.11.063_bib47","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/apt.12431","article-title":"Systematic review: IBD-associated pyoderma gangrenosum in the biologic era, the response to therapy","volume":"38","author":"Agarwal","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaad.2017.11.063_bib48","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/gut.2005.074815","article-title":"Infliximab for the\u00a0treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial","volume":"55","author":"Brooklyn","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jaad.2017.11.063_bib49","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1111\/j.1572-0241.2003.07581.x","article-title":"Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease","volume":"98","author":"Regueiro","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaad.2017.11.063_bib50","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/j.1365-4632.2011.05201.x","article-title":"Six patients with pyoderma gangrenosum successfully treated with infliximab","volume":"52","author":"Mooij","year":"2013","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib51","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1365-2133.2005.06467.x","article-title":"Systemic pyoderma gangrenosum responding to infliximab and adalimumab","volume":"152","author":"Hubbard","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib52","first-page":"15","article-title":"Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab","volume":"16","author":"Reddick","year":"2010","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jaad.2017.11.063_bib53","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1365-4632.2007.03286.x","article-title":"Etanercept for the treatment of refractory pyoderma gangrenosum: a brief series","volume":"46","author":"Charles","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib54","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1016\/j.jaad.2005.10.058","article-title":"The treatment of pyoderma gangrenosum using etanercept","volume":"54","author":"Roy","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib55","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1046\/j.1365-2133.1998.02440.x","article-title":"Pyoderma gangrenosum with rheumatoid arthritis and pulmonary aseptic abscess responding to treatment with dapsone","volume":"139","author":"Fukuhara","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib56","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0266-7681(93)90209-X","article-title":"Bilateral pyoderma gangrenosum of the hand: treatment with dapsone","volume":"18","author":"Brown","year":"1993","journal-title":"J Hand Surg Br"},{"key":"10.1016\/j.jaad.2017.11.063_bib57","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2230.1981.tb02294.x","article-title":"Pyoderma gangrenosum: successful treatment with minocycline","volume":"6","author":"Davies","year":"1981","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib58","first-page":"535","article-title":"Pyoderma gangrenosum responsive\u00a0to minocycline hydrochloride","volume":"21","author":"Lynch","year":"1978","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2017.11.063_bib59","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jdcr.2017.05.005","article-title":"Successful combined antibiotic therapy with oral clindamycin and oral rifampicin for pyoderma gangrenosum in patient with PASH syndrome","volume":"4","author":"Lamiaux","year":"2017","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaad.2017.11.063_bib60","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/09546630410020154","article-title":"Mycophenolate mofetil in pyoderma gangrenosum","volume":"15","author":"Lee","year":"2004","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2017.11.063_bib61","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archderm.134.12.1509","article-title":"The effectiveness of mycophenolate mofetil in refractory pyoderma gangrenosum","volume":"134","author":"Nousari","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib62","first-page":"326","article-title":"Treatment of pyoderma gangrenosum with methotrexate","volume":"57","author":"Teitel","year":"1996","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2017.11.063_bib63","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/j.1365-2133.2007.08217.x","article-title":"Treatment of pyoderma gangrenosum with intravenous immunoglobulin","volume":"157","author":"Cummins","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib64","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1365-2230.1999.00424.x","article-title":"Plasmapheresis and cyclophosphamide as successful treatments for pyoderma gangrenosum","volume":"24","author":"Kaminska","year":"1999","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib65","first-page":"1352","article-title":"Intravenous cyclophosphamide pulses in the treatment of pyoderma gangrenosum associated with rheumatoid arthritis: report of 2 cases and review of the literature","volume":"21","author":"Zonana-Nacach","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib66","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1365-2133.2009.09404.x","article-title":"Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra","volume":"161","author":"Brenner","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib67","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jdcr.2016.07.007","article-title":"The role of interleukin-1beta in pyoderma gangrenosum","volume":"2","author":"Galimberti","year":"2016","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaad.2017.11.063_bib68","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/bjd.14037","article-title":"Canakinumab in adults with steroid-refractory pyoderma gangrenosum","volume":"173","author":"Kolios","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib69","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1684\/ejd.2013.2018","article-title":"Pyoderma gangrenosum and concomitant hidradenitis suppurativa\u2014rapid response to\u00a0canakinumab (anti-IL-1beta)","volume":"23","author":"Jaeger","year":"2013","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib70","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/dth.12387","article-title":"High-dose ustekinumab for the treatment of severe, recalcitrant pyoderma gangrenosum","volume":"29","author":"Greb","year":"2016","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2017.11.063_bib71","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jaad.2009.05.030","article-title":"Pyoderma gangrenosum: a review and update on new therapies","volume":"62","author":"Miller","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib72","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1177\/000313481107701236","article-title":"A retrospective study of 12 cases of pyoderma gangrenosum: why we should avoid surgical intervention and what therapy to apply","volume":"77","author":"Baranska-Rybak","year":"2011","journal-title":"Am Surg"},{"key":"10.1016\/j.jaad.2017.11.063_bib73","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaad.2004.10.006","article-title":"Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients","volume":"53","author":"Reichrath","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib74","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaad.2015.08.070","article-title":"Wound healing and treating wounds: chronic wound care and management","volume":"74","author":"Powers","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib75","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2340\/00015555-2008","article-title":"Effective strategies for the management of pyoderma gangrenosum: a comprehensive review","volume":"95","author":"Patel","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2017.11.063_bib76","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jaad.2017.09.040","article-title":"Risk of developing pyoderma gangrenosum after procedures in patients with a known history of pyoderma gangrenosum-A retrospective analysis","volume":"78","author":"Xia","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib77","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2133.1981.tb00774.x","article-title":"The spectrum of inflammatory skin disease following jejuno-ileal bypass for morbid obesity","volume":"105","author":"Kennedy","year":"1981","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib78","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/art.1780240509","article-title":"The intestinal bypass: arthritis-dermatitis syndrome","volume":"24","author":"Stein","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2017.11.063_bib79","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/archderm.1979.04010070013012","article-title":"Bowel bypass syndrome","volume":"115","author":"Dicken","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib80","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0190-9622(86)70095-9","article-title":"Bowel-associated dermatosis-arthritis syndrome: bowel bypass syndrome without bowel bypass","volume":"14","author":"Dicken","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib81","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1111\/j.1365-4632.2011.05149.x","article-title":"Bowel-associated dermatosis-arthritis syndrome: another cutaneous manifestation of inflammatory intestinal disease","volume":"52","author":"Truchuelo","year":"2013","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib82","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1001\/archinte.1983.00350030071013","article-title":"Bowel-bypass syndrome without bowel bypass. Bowel-associated dermatosis-arthritis syndrome","volume":"143","author":"Jorizzo","year":"1983","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaad.2017.11.063_bib83","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s40257-014-0092-6","article-title":"Neutrophilic dermatoses: an update","volume":"15","author":"Alavi","year":"2014","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib84","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1186\/s40064-016-3236-8","article-title":"Is it bowel-associated dermatosis-arthritis syndrome induced by small intestinal bacteria overgrowth?","volume":"5","author":"Zhao","year":"2016","journal-title":"Springerplus"},{"key":"10.1016\/j.jaad.2017.11.063_bib85","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0190-9622(80)80148-4","article-title":"The bowel bypass syndrome: a response to bacterial peptidoglycans","volume":"2","author":"Ely","year":"1980","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib86","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1346-8138.1995.tb03396.x","article-title":"Skin manifestations associated with rheumatoid arthritis","volume":"22","author":"Yamamoto","year":"1995","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib87","first-page":"203","article-title":"Rheumatoid neutrophilic dermatitis","volume":"60","author":"Hirota","year":"1997","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2017.11.063_bib88","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/archderm.1997.03890420097013","article-title":"Rheumatoid neutrophilic dermatitis","volume":"133","author":"Mashek","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib89","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/0190-9622(90)70127-4","article-title":"Rheumatoid neutrophilic dermatitis","volume":"22","author":"Sanchez","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib90","first-page":"133","article-title":"Rheumatoid neutrophilic dermatitis","volume":"78","author":"Bevin","year":"2006","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2017.11.063_bib91","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/095952879708000106","article-title":"On a form of chronic joint disease in children","volume":"80","author":"Still","year":"1897","journal-title":"Med Chir Trans"},{"key":"10.1016\/j.jaad.2017.11.063_bib92","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/ard.30.2.121","article-title":"Still's disease in the adult","volume":"30","author":"Bywaters","year":"1971","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2017.11.063_bib93","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","article-title":"Adult-onset Still's disease","volume":"13","author":"Gerfaud-Valentin","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaad.2017.11.063_bib94","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/art.1780250607","article-title":"Adult-onset Still's disease. Twenty-year followup and further studies of patients with active disease","volume":"25","author":"Elkon","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2017.11.063_bib95","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","article-title":"Adult Still's disease: manifestations, disease course, and outcome in 62 patients","volume":"70","author":"Pouchot","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaad.2017.11.063_bib96","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/cup.12935","article-title":"Clinical and histopathological features of cutaneous manifestations of adult-onset Still disease","volume":"44","author":"Santa","year":"2017","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2017.11.063_bib97","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s10067-014-2614-2","article-title":"Cutaneous manifestations of adult-onset Still's disease: a case report and review of literature","volume":"35","author":"Cozzi","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib98","first-page":"592","article-title":"Severe sore throat as a presenting symptom of adult onset Still's disease: a case series and review of the literature","volume":"24","author":"Nguyen","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib99","first-page":"1058","article-title":"Adult Still's disease: a multicenter survey of Japanese patients","volume":"17","author":"Ohta","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib100","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/ard.47.9.764","article-title":"Adult onset Still's disease and viral infections","volume":"47","author":"Wouters","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2017.11.063_bib101","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1001\/archinte.1984.00350210210040","article-title":"Adult Still's disease caused by Yersinia enterocolitica infection","volume":"144","author":"Colebunders","year":"1984","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaad.2017.11.063_bib102","series-title":"Histologic Diagnosis of Inflammatory Skin Diseases: A Method by Pattern Analysis","first-page":"449","author":"Ackerman","year":"1978"},{"key":"10.1016\/j.jaad.2017.11.063_bib103","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1002\/art.27532","article-title":"Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still's disease","volume":"62","author":"Franchini","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2017.11.063_bib104","first-page":"373","article-title":"Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease","volume":"26","author":"Fautrel","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib105","first-page":"431","article-title":"Low dose methotrexate treatment in adult Still's disease","volume":"19","author":"Aydintug","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib106","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/s10165-008-0126-0","article-title":"Cyclosporin A treatment for Japanese patients with severe adult-onset Still's disease","volume":"19","author":"Mitamura","year":"2009","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib107","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/art.21061","article-title":"Rapid responses to anakinra in patients with refractory\u00a0adult-onset Still's disease","volume":"52","author":"Fitzgerald","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2017.11.063_bib108","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.3899\/jrheum.111549","article-title":"Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still's disease. An open, randomized, multicenter study","volume":"39","author":"Nordstrom","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib109","first-page":"1487","article-title":"Intravenous methylprednisolone pulse therapy in Still's disease","volume":"19","author":"Bisagni-Faure","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10067-003-0775-5","article-title":"Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients","volume":"23","author":"Kokkinos","year":"2004","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaad.2017.11.063_bib111","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","article-title":"Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis","volume":"367","author":"De Benedetti","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2017.11.063_bib112","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/00003495-200868030-00005","article-title":"Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advances","volume":"68","author":"Kontzias","year":"2008","journal-title":"Drugs"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218305036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218305036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:48:13Z","timestamp":1759272493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962218305036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":112,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0190962218305036"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2017.11.063","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutrophilic dermatoses","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2017.11.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S0190-9622(18)32768-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}